First approval worldwide for anabolic agent romosozumab for osteoporosis in women at high risk of fracture. The FDA previously rejected it, but an advisory committee will discuss the agent in 2 weeks.
Medscape Medical News …read more
Miami OBGYN Society
A Membership Organization of South Florida Obstetrician-Gynecologists
